Skip to main content

Continuity of Pharmacotherapy for Opioid Use Disorder

CBE ID
3175
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Spring 2026
1.3 Measure Description

Percentage of adults of at least 18 years of age with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment

        • 1.14 Numerator

          Individuals in the denominator who have at least 180 days of continuous pharmacotherapy with a medication prescribed for OUD without a gap of more than seven days

        • 1.15 Denominator

          Individuals at least 18 years of age who had a diagnosis of OUD and at least one claim for an OUD medication

        • Exclusions

          There are no denominator exclusions.

        • 1.13a Data dictionary not attached
          No
        • Most Recent Endorsement Activity
          Endorsed Behavioral Health and Substance Use Spring Cycle 2021
          Initial Endorsement
          Last Updated
        • Steward
          University of Southern California
          Steward Organization POC Email
          Steward Organization Copyright

          Some proprietary codes are contained in the measure specifications for convenience of the user. Use of these codes may require permission from the code owner or agreement to a license.

          ICD-10 codes are copyrighted © World Health Organization (WHO), Fourth Edition, 2021. CPT © 2021 American Medical Association. CPT is a registered trademark of the American Medical Association. All rights reserved.

              • Risk adjustment approach
                Off
                Risk adjustment approach
                Off
                Conceptual model for risk adjustment
                Off
                Conceptual model for risk adjustment
                Off